Palmer Luckey's Warhound Raises $200 Million to Engineer Military Dogs

A startup founded by Palmer Luckey says it will genetically modify dogs for military use.

Warhound announced on 23 October 2026 that it has raised $200 million from investors, a group that includes Sequoia. The company says the modified animals will detect explosives and help protect troops. Colossal Biosciences is reportedly collaborating with Warhound on the cloning and gene-editing work required to produce the animals.

The funding gives Warhound substantial capital to pursue a specific capability: dogs bred and edited to locate explosives in the field. That task has historically relied on training programs that take months per animal. The source does not state how many dogs Warhound intends to produce, what genes it plans to alter, or when working animals might be deployed.

The reports do not clarify the terms of the investment, whether Sequoia led the round, or what stake investors received for their $200 million. It is also unclear how Warhound's gene-editing approach differs from conventional selective breeding, or what regulatory path military dogs altered at the genetic level would need to clear before field use.

Colossal Biosciences has worked on cloning and gene editing in other species. The source does not describe the scope of its role at Warhound, including whether the company is providing technology, laboratory capacity, or expertise in a limited capacity.

Warhound's announcement lands amid a wider set of developments reported on 23 October 2026, including a 42% reduction in deaths recorded in a Moderna and Merck mRNA cancer vaccine trial and the first human patient treated with prime editing, a technique that rewrites DNA in liver cells.